Diabetic neuropathy: An evaluation of the use of quercetin in the cecum of rats

World Journal of Gastroenterology

Volumn 19, Issue 38, 2013, Pages 6416-6426

  Ferreira, Paulo Emilio Botura ^a   Lopes, Cláudia Regina Pinheiro ^a   Alves, Angela Maria Pereira ^a   Alves, Éder Paulo Belato ^a   Linden, David Robert ^b   Zanoni, Jacqueline Nelisis ^a   Buttow, Nilza Cristina ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Diabetes; Enteric glia; Myenteric plexus; Neuronal nitric oxide synthase; Neuroprotection; Vasoactive intestinal polypeptide

Indexed keywords

GLUCOSE; HUC PROTEIN; HUD PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN S 100; QUERCETIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CECUM; CELL DENSITY; CELL LOSS; CONTROLLED STUDY; DIABETIC NEUROPATHY; FLUORESCENCE MICROSCOPY; GLIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MORPHOMETRICS; MYENTERIC PLEXUS; NEUROPROTECTION; NONHUMAN; RAT; VARICOSIS;

DIABETES; ENTERIC GLIA; MYENTERIC PLEXUS; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTION; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMALS; CECUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; MALE; MYENTERIC PLEXUS; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRERGIC NEURONS; NITRIC OXIDE SYNTHASE TYPE I; QUERCETIN; RATS; RATS, WISTAR; S100 PROTEINS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84885646002     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i38.6416     Document Type: Article

References (54)

1. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989-1996 [PMID: 11525701 DOI: 10.1001/archinte.161.16.1989]
2. Lopes CR, Ferreira PE, Zanoni JN, Alves AM, Alves EP, Buttow NC. Neuroprotective effect of quercetin on the duodenum enteric nervous system of streptozotocin-induced diabetic rats. Dig Dis Sci 2012; 57: 3106-3115 [PMID: 22878915 DOI: 10.1007/s10620-012-2300-7]
3. Shotton HR, Adams A, Lincoln J. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum. Auton Neurosci 2007; 132: 16-26 [PMID: 16987713 DOI: 10.1016/j.autneu.2006.08.007]
4. Zanoni JN, Pereira PGC, Pereira MAS. Analysis of myenteric neurons of the cecum of diabetic rats after supplementation with ascorbic acid. Int J Morphol 2009; 27: 387-392 [DOI: 10.4067/S0717-95022009000200013]
5. da Silva GG, Zanoni JN, Buttow NC. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol 2011; 17: 898-905 [PMID: 21412498 DOI: 10.3748/wjg.v17.i7.898]
6. Pereira RV, de Miranda-Neto MH, da Silva Souza ID, Zanoni JN. Vitamin E supplementation in rats with experimental diabetes mellitus: analysis of myosin-V and nNOS immunoreactive myenteric neurons from terminal ileum. J Mol Histol 2008; 39: 595-603 [PMID: 18953659 DOI: 10.1007/ s10735-008-9200-3]
7. Voukali E, Shotton HR, Lincoln J. Selective responses of myenteric neurons to oxidative stress and diabetic stimuli. Neurogastroenterol Motil 2011; 23: 964-e411 [PMID: 21914042 DOI: 10.1111/j.1365-2982.2011.01778.x]
8. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 2008; 9: 36-45 [PMID: 18094705 DOI: 10.1038/ nrn2294]
9. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002; 5: 561-568 [PMID: 12172481 DOI: 10.1097/00075197-200209000-00016]
10. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267 [PMID: 8742574 DOI: 10.2337/diacare.19.3.257]
11. Young IS, Torney JJ, Trimble ER. The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1992; 13: 41-46 [PMID: 1628852 DOI: 10.1016/0891-5849(92)90164-C]
12. Shirpoor A, Ilkhanizadeh B, Saadatian R, Darvari BS, Behtaj F, Karimipour M, Ghaderi-Pakdel F, Saboori E. Effect of vitamin E on diabetes-induced changes in small intestine and plasma antioxidant capacity in rat. J Physiol Biochem 2006; 62: 171-177 [PMID: 17451158 DOI: 10.1007/BF03168466]
13. Erdman JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007; 137: 718S-737S [PMID: 17311968]
14. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-425 [PMID: 11566638]
15. Kahraman A, Erkasap N, Köken T, Serteser M, Aktepe F, Erkasap S. The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesions. Toxicology 2003; 183: 133-142 [PMID: 12504347 DOI: 10.1016/S0300-483X(02)00514-0]
16. Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33: 1061-1080 [PMID: 8847003 DOI: 10.1016/0278-6915(95)00077-1]
17. Furness JB. The Enteric Nervous System. 1st ed. New York: Churchill Livingstone, 2005: 20-23
18. Rühl A, Nasser Y, Sharkey KA. Enteric glia. Neurogastroenterol Motil 2004; 16 Suppl 1: 44-49 [PMID: 15066004 DOI: 10.1111/j.1743-3150.2004.00474.x]
19. Aubé AC, Cabarrocas J, Bauer J, Philippe D, Aubert P, Doulay F, Liblau R, Galmiche JP, Neunlist M. Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut 2006; 55: 630-637 [PMID: 16236773 DOI: 10.1136/gut.2005.067595]
20. Bergmeyer HU, Bernet E. Determination of glucose-oxidase and peroxidase. In: Methods of enzymatic analysis. 2nd ed. New York, NY: Verlag Chemie-Academic Press, 1974: 6
21. Stefanini M, De Martino C, Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature 1967; 216: 173-174 [PMID: 4862079 DOI: 10.1038/216173a0]
22. Silva EA, Natali MRM, Prado IMM. The number and profile of reative NADH-d and NADPH-d neurons of myenteric plexus of six-month-old rats are different in the cecum portions. Pesquisa Veterinária Brasileira 2008; 28: 241-248
23. Cowen T, Johnson RJ, Soubeyre V, Santer RM. Restricted diet rescues rat enteric motor neurones from age related cell death. Gut 2000; 47: 653-660 [PMID: 11034581 DOI: 10.1136/ gut.47.5.653]
24. Schmidt RE. Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiol 2002; 50: 257-292 [PMID: 12198813 DOI: 10.1016/S0074-7742(02)50080-5]
25. De Miranda-Neto M, Fregonesi C, Molinary S, Alves A, Defani M, Zanoni J, Bazzote R. Evaluation of the nitrergic myenteric neurons in the distal colon of diabetic rats treated with acety-l-carnitine. Braz J Morphol Sci 2004; 21: 105-110
26. Zanoni JN, de Miranda Neto MH, Bazotte RB, de Souza RR. Morphological and quantitative analysis of the neurons of the myenteric plexus of the cecum of streptozotocin-induced diabetic rats. Arq Neuropsiquiatr 1997; 55: 696-702 [PMID: 9629327 DOI: 10.1590/S0004-282X1997000500004]
27. Fregonesi CE, Molinari SL, Alves AM, Defani MA, Zanoni JN, Bazotte RB, de Miranda Neto MH. Morphoquantitative aspects of nitrergic myoenteric neurons from the stomach of diabetic rats supplemented with acetyl-L-carnitine. Anat Histol Embryol 2005; 34: 93-97 [PMID: 15771670 DOI: 10.1111/ j.1439-0264.2004.00578.x]
28. Büttow NC, Miranda Neto MH, Bazotte RB. Morphological and quantitative study of the myenteric plexus of the duodenum of streptozotocin-induced diabetic rats. Arq Gastroenterol 1997; 34: 34-42 [PMID: 9458958]
29. Zanoni J, Pereira R, Freitas P. Effect of the ascorbic acid treatment on the NADHd-positive myenteric neurons of diabetic rats proximal colon. Braz Arch Biol Techn 2007; 50: 31-38 [DOI: 10.1590/S1516-89132007000100004]
30. Kuyvenhoven JP, Meinders AE. Oxidative stress and diabetes mellitus Pathogenesis of long-term complications. Eur J Inter Med 1999; 10: 9-19 [DOI: 10.1016/S0953-6205(99)00009-6]
31. Chandrasekharan B, Anitha M, Blatt R, Shahnavaz N, Kooby D, Staley C, Mwangi S, Jones DP, Sitaraman SV, Srinivasan S. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil 2011; 23: 131-18, e26 [PMID: 20939847 DOI: 10.1111/j.1365-2982.2010.01611.x]
32. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004; 25: 612-628 [PMID: 15294884 DOI: 10.1210/ er.2003-0019]
33. Hollman PC, vd Gaag M, Mengelers MJ, van Trijp JM, de Vries JH, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996; 21: 703-707 [PMID: 8891673 DOI: 10.1016/0891-5849(96)00129-3]
34. Arredondo F, Echeverry C, Abin-Carriquiry JA, Blasina F, Antúnez K, Jones DP, Go YM, Liang YL, Dajas F. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med 2010; 49: 738-747 [PMID: 20554019 DOI: 10.1016/j.freeradbiomed.2 010.05.020]
35. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003; 52: 2353-2362 [PMID: 12941776 DOI: 10.2337/diabetes. 52.9.2353]
36. Cellek S, Qu W, Schmidt AM, Moncada S. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia 2004; 47: 331-339 [PMID: 14676945 DOI: 10.1007/s00125-003-1298-y]
37. Takahashi T, Nakamura K, Itoh H, Sima AA, Owyang C. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997; 113: 1535-1544 [PMID: 9352855 DOI: 10.1053/ gast.1997.v113.pm9352855]
38. Wrzos HF, Cruz A, Polavarapu R, Shearer D, Ouyang A. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci 1997; 42: 2106-2110 [PMID: 9365143 DOI: 10.1023/A:]
39. Adeghate E, al-Ramadi B, Saleh AM, Vijayarasathy C, Ponery AS, Arafat K, Howarth FC, El-Sharkawy T. Increase in neuronal nitric oxide synthase content of the gastroduodenal tract of diabetic rats. Cell Mol Life Sci 2003; 60: 1172-1179 [PMID: 12861383]
40. Alves EP, Alves AM, Pereira RV, de Miranda Neto MH, Zanoni JN. Immunohistochemical study of vasoactive intestinal peptide (VIP) enteric neurons in diabetic rats supplemented with L-glutamine. Nutr Neurosci 2010; 13: 43-51 [PMID: 20132654 DOI: 10.1179/147683010X12611460763841]
41. Masmoudi-Kouki O, Gandolfo P, Castel H, Leprince J, Fournier A, Dejda A, Vaudry H, Tonon MC. Role of PACAP and VIP in astroglial functions. Peptides 2007; 28: 1753-1760 [PMID: 17655978 DOI: 10.1016/j.peptides.2007.05.015]
42. Delgado M, Ganea D. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. FASEB J 2003; 17: 1922-1924 [PMID: 12923064 DOI: 10.1096/fj.02-1029fje]
43. Blondel O, Collin C, McCarran WJ, Zhu S, Zamostiano R, Gozes I, Brenneman DE, McKay RD. A glia-derived signal regulating neuronal differentiation. J Neurosci 2000; 20: 8012-8020 [PMID: 11050122]
44. Konturek PC, Brzozowski T, Burnat G, Szlachcic A, Koziel J, Kwiecien S, Konturek SJ, Harsch IA. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. J Physiol Pharmacol 2010; 61: 429-436 [PMID: 20814070]
45. Dasu MR, Devaraj S, Jialal I. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab 2007; 293: E337-E346 [PMID: 17426109 DOI: 10.1152/ajpendo.00718.2006]
46. Rühl A, Franzke S, Stremmel W. IL-1beta and IL-10 have dual effects on enteric glial cell proliferation. Neurogastroenterol Motil 2001; 13: 89-94 [PMID: 11169130 DOI: 10.1046/ j.1365-2982.2001.00245.x]
47. Zanoni JN, Hernandes L, Bazotte RB, Miranda Neto MH. neurons of diabetic rats treated with ascorbic acid. Arq Neuropsiquiatr 2002; 60: 32-37 [PMID: 11965406 DOI: 10.1590/ S0004-282X2002000100007]
48. Ekblad E, Mulder H, Sundler F. Vasoactive intestinal peptide expression in enteric neurons is upregulated by both colchicine and axotomy. Regul Pept 1996; 63: 113-121 [PMID: 8837219 DOI: 10.1016/S0167-0115(96)00028-6]
49. Misra BR, Misra HP. Vasoactive intestinal peptide, a singlet oxygen quencher. J Biol Chem 1990; 265: 15371-15374 [PMID: 2168410]
50. Sandgren K, Lin Z, Ekblad E. Differential effects of VIP and PACAP on survival of cultured adult rat myenteric neurons. Regul Pept 2003; 111: 211-217 [PMID: 12609771 DOI: 10.1016/ S0167-0115(02)00290-2]
51. Said SI. The Viktor Mutt Memorial Lecture. Protection by VIP and related peptides against cell death and tissue injury. Ann N Y Acad Sci 2000; 921: 264-274 [PMID: 11193833 DOI: 10.1111/j.1749-6632.2000.tb06975.x]
52. Pereira MA, Bagatin MC, Zanoni JN. Effects of the ascorbic acid supplementation on NADH-diaphorase myenteric neurons in the duodenum of diabetic rats. Biocell 2006; 30: 295-300 [PMID: 16972554]
53. Rühl A. Glial regulation of neuronal plasticity in the gut: implications for clinicians. Gut 2006; 55: 600-602 [PMID: 16609131 DOI: 10.1136/gut.2005.084426]
54. von Boyen GB, Reinshagen M, Steinkamp M, Adler G, Kirsch J. Enteric nervous plasticity and development: dependence on neurotrophic factors. J Gastroenterol 2002; 37: 583-588 [PMID: 12203072 DOI: 10.1007/s005350200093]